Home › Asset managers › Compare 2025-2026 › BlackRock vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,248 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
BlackRock 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 37,817 | 27,805 | 2,443 | 7,569 | 91.9% | 85.0% |
| Board proposals | 30,219 | 21,602 | 2,017 | 6,600 | 91.5% | 84.4% |
| E&S shareholder proposals | 162 | 0 | 1 | 161 | 0.0% | 38.4% |
| Other items | 7,436 | 6,203 | 425 | 808 | 93.6% | 88.2% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
6,600 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | BlackRock | Brighthouse |
|---|---|---|---|---|---|---|
| BAXTER INTERNATIONAL INC. | May 5, 2026 | Approval of the Baxter International Inc. Second Amended and Restated 2021 Incentive Plan Compensation |
Board | For | FOR 35 funds |
Split 4 AGAINST, 2 ABSTAIN |
| BAXTER INTERNATIONAL INC. | May 5, 2026 | Ratification of Appointment of Independent Registered Public Accounting Firm for 2026 Audit-related |
Board | For | FOR 35 funds |
Split 4 FOR, 2 ABSTAIN |
| BAYER AG | April 24, 2026 | Appoint Deloitte GmbH as Auditor for Sustainability Reporting for Fiscal Year 2026 Audit-related |
Board | For | Split 2 FOR, 21 ABSTAIN |
FOR 3 funds |
| BEACON FINANCIAL CORPORATION | May 13, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 28 funds |
Split 1 FOR, 2 AGAINST, 1 ABSTAIN |
| BEACON FINANCIAL CORPORATION | May 13, 2026 | To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 14 funds |
Split 3 FOR, 1 ABSTAIN |
| BEAM THERAPEUTICS INC. | June 3, 2026 | Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 31 funds |
Split 4 FOR, 2 ABSTAIN |
| BEAM THERAPEUTICS INC. | June 3, 2026 | Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029. John Evans Director Elections |
Board | For | FOR 19 funds |
Split 1 FOR, 2 ABSTAIN |
| BEAM THERAPEUTICS INC. | June 3, 2026 | Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 19 funds |
Split 4 FOR, 2 ABSTAIN |
| BEAZLEY PLC | April 22, 2026 | Approve Remuneration Policy Say-on-Pay |
Board | For | FOR 21 funds |
Split 1 FOR, 1 AGAINST |
| BECTON DICKINSON & CO. | January 27, 2026 | Advisory Vote to Ratify Named Executive Officers' Compensation Say-on-Pay |
Board | For | FOR 2 funds |
Split 1 FOR, 1 AGAINST, 1 ABSTAIN |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | Approval of an amendment to the 2004 Employee and Director Equity-Based Compensation Plan Compensation |
Board | For | FOR 49 funds |
Split 7 FOR, 1 ABSTAIN |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | Election of Directors: Bertram L. Scott Director Elections |
Board | For | FOR 49 funds |
Split 7 FOR, 1 ABSTAIN |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | Election of Directors: Carrie L. Byington Director Elections |
Board | For | FOR 49 funds |
Split 7 FOR, 1 ABSTAIN |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | Election of Directors: Christopher Jones Director Elections |
Board | For | FOR 49 funds |
Split 6 FOR, 1 AGAINST, 1 ABSTAIN |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | Election of Directors: Claire M. Fraser Director Elections |
Board | For | FOR 49 funds |
Split 7 FOR, 1 ABSTAIN |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | Election of Directors: Gregory J. Hayes Director Elections |
Board | For | FOR 49 funds |
Split 7 FOR, 1 ABSTAIN |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | Election of Directors: Jacqueline Wright Director Elections |
Board | For | FOR 49 funds |
Split 7 FOR, 1 ABSTAIN |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | Election of Directors: Jeffrey W. Henderson Director Elections |
Board | For | FOR 49 funds |
Split 7 FOR, 1 ABSTAIN |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | Election of Directors: Joanne Waldstreicher Director Elections |
Board | For | FOR 49 funds |
Split 7 FOR, 1 ABSTAIN |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | Election of Directors: R. Andrew Eckert Director Elections |
Board | For | FOR 49 funds |
Split 7 FOR, 1 ABSTAIN |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | Election of Directors: Robert L. Huffines Director Elections |
Board | For | FOR 49 funds |
Split 7 FOR, 1 ABSTAIN |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | Election of Directors: Thomas E. Polen Director Elections |
Board | For | FOR 49 funds |
Split 7 FOR, 1 ABSTAIN |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | Election of Directors: Timothy M. Ring Director Elections |
Board | For | FOR 49 funds |
Split 7 FOR, 1 ABSTAIN |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | Election of Directors: William M. Brown Director Elections |
Board | For | FOR 49 funds |
Split 7 FOR, 1 ABSTAIN |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | Ratification of the selection of the independent registered public accounting firm Audit-related |
Board | For | FOR 49 funds |
Split 6 FOR, 1 AGAINST, 1 ABSTAIN |
| BEIJER REF AB | April 23, 2026 | APPROVE ALTERNATIVE EQUITY PLAN FINANCING OF LTI 2026, IF ITEM 15.B IS NOT APPROVED Compensation |
Board | For | Split 13 FOR, 2 AGAINST |
AGAINST 2 funds |
| BEIJER REF AB | April 23, 2026 | APPROVE PERFORMANCE SHARE MATCHING PLAN LTI 2026 FOR KEY EMPLOYEES Compensation |
Board | For | Split 13 FOR, 2 AGAINST |
AGAINST 2 funds |
| BEIJER REF AB | April 23, 2026 | ELECT PER BERTLAND AS BOARD CHAIR Corporate Governance |
Board | For | Split 14 FOR, 1 AGAINST |
AGAINST 2 funds |
| BEIJER REF AB | April 23, 2026 | RATIFY DELOITTE AS AUDITORS Audit-related |
Board | For | Split 2 FOR, 13 AGAINST |
FOR 2 funds |
| BEIJER REF AB | April 23, 2026 | REELECT ALBERT GUSTAFSSON AS DIRECTOR Director Elections |
Board | For | Split 14 FOR, 1 AGAINST |
AGAINST 2 funds |
| BEIJER REF AB | April 23, 2026 | REELECT NATHALIE DELBREUVE AS DIRECTOR Director Elections |
Board | For | Split 14 FOR, 1 AGAINST |
FOR 2 funds |
| BEIJER REF AB | April 23, 2026 | REELECT PER BERTLAND AS DIRECTOR Director Elections |
Board | For | Split 13 FOR, 2 AGAINST |
AGAINST 2 funds |
| BEIJER REF AB | April 23, 2026 | REELECT WILLIAM STRIEBE AS DIRECTOR Director Elections |
Board | For | Split 2 FOR, 13 AGAINST |
AGAINST 2 funds |
| BELDEN INC. | May 21, 2026 | Advisory vote on executive compensation for 2025. Say-on-Pay |
Board | For | FOR 35 funds |
Split 6 FOR, 1 ABSTAIN |
| BELDEN INC. | May 21, 2026 | Amendment and Restatement of the Belden 2021 Long Term Incentive Plan. Compensation |
Board | For | FOR 21 funds |
Split 6 FOR, 1 ABSTAIN |
| BELDEN INC. | May 21, 2026 | Ratification of the appointment of Ernst & Young as the Company's Independent Registered Public Accounting Firm for 2026. Audit-related |
Board | For | FOR 21 funds |
Split 6 FOR, 1 ABSTAIN |
| BELLRING BRANDS, INC. | January 28, 2026 | Election of Directors: Chonda J. Nwamu Director Elections |
Board | For | FOR 27 funds |
Split 6 FOR, 1 WITHHOLD |
| BELLRING BRANDS, INC. | January 28, 2026 | Election of Directors: Darcy Horn Davenport Director Elections |
Board | For | FOR 27 funds |
Split 6 FOR, 1 WITHHOLD |
| BELLRING BRANDS, INC. | January 28, 2026 | Election of Directors: David I. Finkelstein Director Elections |
Board | For | FOR 27 funds |
Split 6 FOR, 1 WITHHOLD |
| BELLRING BRANDS, INC. | January 28, 2026 | Election of Directors: Elliot H. Stein, Jr. Director Elections |
Board | For | FOR 27 funds |
Split 6 FOR, 1 WITHHOLD |
| BELLRING BRANDS, INC. | January 28, 2026 | Election of Directors: Robert V. Vitale Director Elections |
Board | For | WITHHOLD 27 funds |
Split 6 FOR, 1 WITHHOLD |
| BELLRING BRANDS, INC. | January 28, 2026 | The ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2026. Audit-related |
Board | For | FOR 27 funds |
Split 6 FOR, 1 ABSTAIN |
| BELLRING BRANDS, INC. | January 28, 2026 | To consider and vote, on an advisory basis, for the adoption of a resolution approving the compensation of our named executive officers, as such compensation is described under the "Compensation Discussion and Analysis" and "Executive Compensation" sections of this proxy statement. Say-on-Pay |
Board | For | FOR 42 funds |
Split 3 FOR, 3 AGAINST, 1 ABSTAIN |
| BENCHMARK ELECTRONICS, INC. | May 28, 2026 | To approve an amendment to the Benchmark Electronics, Inc. 2019 Omnibus Incentive Compensation Plan to increase the total number of authorized shares of the Company's common stock available for grant hereunder by 1,800,000 shares; and Compensation |
Board | For | FOR 17 funds |
Split 2 FOR, 1 AGAINST, 1 ABSTAIN |
| BENCHMARK ELECTRONICS, INC. | May 28, 2026 | To elect nine directors to serve on the Board of Directors until the 2027 annual meeting of shareholders and until their successors are duly elected and qualified: David W. Scheible Director Elections |
Board | For | FOR 17 funds |
Split 2 FOR, 1 ABSTAIN |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | To approve, on an advisory (non-binding) basis, the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 46 funds |
Split 2 FOR, 2 ABSTAIN |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 32 funds |
Split 2 FOR, 2 ABSTAIN |
| BERKSHIRE HATHAWAY INC. | May 2, 2026 | Non-binding resolution to approve the compensation of the Company's Named Executive Officers, as described in the 2026 Proxy Statement. Say-on-Pay |
Board | For | FOR 75 funds |
Split 2 FOR, 7 AGAINST, 6 ABSTAIN |
| BEST BUY CO., INC. | June 12, 2026 | To approve in a non-binding advisory vote our named executive officer compensation Say-on-Pay |
Board | For | FOR 74 funds |
Split 4 FOR, 2 ABSTAIN |
| BEST BUY CO., INC. | June 12, 2026 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending January 30, 2027 Audit-related |
Board | For | FOR 55 funds |
Split 4 FOR, 2 ABSTAIN |
| BETA BIONICS, INC. | May 21, 2026 | To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 9 funds |
Split 3 FOR, 1 ABSTAIN |
| BGC GROUP INC. | November 12, 2025 | Approval of the ratification of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for fiscal year 2025. Audit-related |
Board | For | FOR 20 funds |
Split 2 FOR, 2 ABSTAIN |
| BGC GROUP INC. | November 12, 2025 | Approval, on an advisory basis, of executive compensation. Say-on-Pay |
Board | For | FOR 32 funds |
Split 2 AGAINST, 2 ABSTAIN |
| BIC(SOCIETE) | May 20, 2026 | APPROVE COMPENSATION OF GONZALVE BICH, CEO UNTIL SEPTEMBER 15, 2025 Say-on-Pay |
Board | For | Split 13 FOR, 2 AGAINST |
AGAINST 1 fund |
| BIC(SOCIETE) | May 20, 2026 | APPROVE COMPENSATION OF ROB VERSLOOT, CEO FROM SEPTEMBER 15, 2025 Say-on-Pay |
Board | For | Split 13 FOR, 2 AGAINST |
AGAINST 1 fund |
| BIC(SOCIETE) | May 20, 2026 | APPROVE REMUNERATION POLICY OF CHAIRMAN OF THE BOARD Say-on-Pay |
Board | For | Split 2 FOR, 13 AGAINST |
FOR 1 fund |
| BICARA THERAPEUTICS INC. | June 9, 2026 | To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal. Christopher Bowden, M.D. Director Elections |
Board | For | FOR 12 funds |
Split 1 FOR, 2 WITHHOLD |
| BIGBEAR.AI HOLDINGS, INC. | June 9, 2026 | To approve an advisory vote on our executive compensation. Say-on-Pay |
Board | For | Split 20 FOR, 3 AGAINST |
FOR 2 funds |
| BILL HOLDINGS, INC. | December 11, 2025 | To approve, on an advisory basis, the compensation of our Named Executive Officers (Say-on-Pay). Say-on-Pay |
Board | For | FOR 37 funds |
Split 4 FOR, 2 ABSTAIN |
| BILL HOLDINGS, INC. | December 11, 2025 | To ratify the appointment of PricewaterhouseCoopers LLP as our Independent Registered Public Accounting Firm for the Fiscal Year ending June 30, 2026. Audit-related |
Board | For | FOR 23 funds |
Split 4 FOR, 2 ABSTAIN |
| BILLIONTOONE, INC. | June 10, 2026 | Ratify the appointment of PricewaterhouseCoopers LLP as BillionToOne, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 1 FOR, 1 ABSTAIN |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 44 funds |
Split 2 FOR, 1 ABSTAIN |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Approval of the Amended Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan. Compensation |
Board | For | FOR 28 funds |
Split 2 FOR, 1 ABSTAIN |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Nominees: Arnold A. Pinkston Director Elections |
Board | For | FOR 28 funds |
Split 2 FOR, 1 ABSTAIN |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Nominees: Melinda Litherland Director Elections |
Board | For | FOR 28 funds |
Split 2 FOR, 1 ABSTAIN |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors. Audit-related |
Board | For | FOR 28 funds |
Split 2 FOR, 1 ABSTAIN |
| BIO-TECHNE CORP | October 30, 2025 | Approve, on an advisory basis, the compensation of our executive officers. Say-on-Pay |
Board | For | Split 35 FOR, 8 AGAINST |
Split 3 FOR, 3 AGAINST, 3 ABSTAIN |
| BIO-TECHNE CORP | October 30, 2025 | Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 2026 fiscal year. Audit-related |
Board | For | FOR 31 funds |
Split 6 FOR, 3 ABSTAIN |
| BIOCRYST PHARMACEUTICALS, INC. | June 11, 2026 | To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. Compensation |
Board | For | FOR 16 funds |
Split 3 AGAINST, 1 ABSTAIN |
| BIOCRYST PHARMACEUTICALS, INC. | June 11, 2026 | To hold a non-binding, advisory vote regarding executive compensation. Say-on-Pay |
Board | For | Split 6 FOR, 20 AGAINST |
Split 3 AGAINST, 1 ABSTAIN |
| BIOCRYST PHARMACEUTICALS, INC. | June 11, 2026 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for 2026. Audit-related |
Board | For | FOR 16 funds |
Split 3 FOR, 1 ABSTAIN |
| BIOGEN INC. | June 9, 2026 | Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified. Maria C. Freire Director Elections |
Board | For | FOR 61 funds |
Split 5 FOR, 6 ABSTAIN |
| BIOGEN INC. | June 9, 2026 | Say on Pay - To hold an advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 81 funds |
Split 5 FOR, 1 AGAINST, 6 ABSTAIN |
| BIOGEN INC. | June 9, 2026 | To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 61 funds |
Split 5 FOR, 1 AGAINST, 6 ABSTAIN |
| BIOHAVEN LTD | April 28, 2026 | A non-binding advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 35 funds |
Split 4 FOR, 1 ABSTAIN |
| BIOHAVEN LTD | April 28, 2026 | Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. Heffernan Director Elections |
Board | For | FOR 20 funds |
Split 1 FOR, 2 AGAINST |
| BIOHAVEN LTD | April 28, 2026 | Ratification of appointment of Ernst & Young LLP as independent auditors for fiscal year 2026. Audit-related |
Board | For | FOR 20 funds |
Split 4 FOR, 1 ABSTAIN |
| BIOMARIN PHARMACEUTICAL INC. | June 2, 2026 | To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended. Compensation |
Board | For | FOR 41 funds |
Split 4 FOR, 1 ABSTAIN |
| BIOMARIN PHARMACEUTICAL INC. | June 2, 2026 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 59 funds |
Split 2 FOR, 2 AGAINST, 1 ABSTAIN |
| BIOMARIN PHARMACEUTICAL INC. | June 2, 2026 | To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 41 funds |
Split 4 FOR, 1 ABSTAIN |
| BIOMERIEUX SA | May 28, 2026 | APPROVE COMPENSATION OF ALEXANDRE MERIEUX, CHAIRMAN OF THE BOARD Say-on-Pay |
Board | For | Split 35 FOR, 2 AGAINST |
Split 3 FOR, 1 AGAINST |
| BIOMERIEUX SA | May 28, 2026 | APPROVE COMPENSATION OF PIERRE BOULUD, CEO Say-on-Pay |
Board | For | Split 22 FOR, 7 AGAINST |
AGAINST 4 funds |
| BIOMERIEUX SA | May 28, 2026 | APPROVE REMUNERATION OF DIRECTORS IN THE AGGREGATE AMOUNT OF EUR 700,000 Compensation |
Board | For | Split 3 FOR, 17 AGAINST |
FOR 4 funds |
| BIOMERIEUX SA | May 28, 2026 | APPROVE REMUNERATION POLICY OF CEO Say-on-Pay |
Board | For | Split 22 FOR, 7 AGAINST |
AGAINST 4 funds |
| BIOMERIEUX SA | May 28, 2026 | APPROVE REMUNERATION POLICY OF CHAIRMAN OF THE BOARD Say-on-Pay |
Board | For | Split 25 FOR, 5 AGAINST |
AGAINST 4 funds |
| BIOMERIEUX SA | May 28, 2026 | APPROVE REMUNERATION POLICY OF CORPORATE OFFICERS Say-on-Pay |
Board | For | Split 22 FOR, 7 AGAINST |
AGAINST 4 funds |
| BIOMERIEUX SA | May 28, 2026 | AUTHORIZE CAPITAL ISSUANCES FOR USE IN EMPLOYEE STOCK PURCHASE PLANS Compensation |
Board | For | Split 1 FOR, 19 AGAINST |
FOR 4 funds |
| BIOMERIEUX SA | May 28, 2026 | AUTHORIZE DECREASE IN SHARE CAPITAL VIA CANCELLATION OF REPURCHASED SHARES Capital Structure |
Board | For | Split 3 FOR, 17 AGAINST |
FOR 4 funds |
| BIOMERIEUX SA | May 28, 2026 | AUTHORIZE REPURCHASE OF UP TO 10 PERCENT OF ISSUED SHARE CAPITAL Capital Structure |
Board | For | Split 1 FOR, 19 AGAINST |
FOR 4 funds |
| BIOMERIEUX SA | May 28, 2026 | AUTHORIZE UP TO 10 PERCENT OF ISSUED CAPITAL FOR USE IN STOCK OPTION PLANS Compensation |
Board | For | Split 2 FOR, 18 AGAINST |
AGAINST 4 funds |
| BIOMERIEUX SA | May 28, 2026 | REELECT ALEXANDRE MERIEUX AS DIRECTOR Director Elections |
Board | For | Split 19 FOR, 1 AGAINST |
AGAINST 2 funds |
| BIONTECH SE | May 15, 2026 | Approve Remuneration Report Say-on-Pay |
Board | For | AGAINST 1 fund |
Split 1 FOR, 1 AGAINST |
| BIONTECH SE | May 15, 2026 | Elections to the Supervisory Board: Prof. Dr. Iris Loew-Friedrich Director Elections |
Board | For | Split 6 FOR, 3 AGAINST |
FOR 1 fund |
| BIONTECH SE | May 15, 2026 | Elections to the Supervisory Board: Prof. Dr. Rudolf Staudigl Director Elections |
Board | For | Split 6 FOR, 3 AGAINST |
FOR 1 fund |
| BIONTECH SE | May 15, 2026 | Resolution on the appointment of the auditor and the Group auditor for the 2026 financial year and the auditor for any audit or review of interim reports Audit-related |
Board | For | FOR 9 funds |
Split 1 FOR, 1 ABSTAIN |
| BIONTECH SE | May 15, 2026 | Resolution on the appropriation of the balance sheet profit for the 2025 financial year Capital Structure |
Board | For | FOR 9 funds |
Split 1 FOR, 1 ABSTAIN |
| BIONTECH SE | May 15, 2026 | Resolution on the approval of the Compensation Report Say-on-Pay |
Board | For | AGAINST 22 funds |
Split 1 FOR, 1 ABSTAIN |
| BIONTECH SE | May 15, 2026 | Resolution on the approval of the conclusion of a domination and profit and loss transfer agreement between BioNTech SE and BioNTech Discovery GmbH Extraordinary Transactions |
Board | For | FOR 9 funds |
Split 1 FOR, 1 ABSTAIN |
| BIONTECH SE | May 15, 2026 | Resolution on the cancellation of the existing Authorized Capital 2025 and the creation of new Authorized Capital 2026 with the possibility of excluding subscription rights and corresponding amendment to the Articles of Association Capital Structure |
Board | For | FOR 9 funds |
Split 1 FOR, 1 AGAINST |
| BITMINE IMMERSION TECHNOLOGIES, INC. | January 15, 2026 | To approve the charter amendment to increase the number of authorized shares of Common Stock. Capital Structure |
Board | Not determined | AGAINST 10 funds |
Split 1 FOR, 2 AGAINST |
← Previous Page 9 of 66 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.